Oriola Oyj (HEL:ORIOLA)

Market Cap	176.17M -16.0%
Revenue (ttm)	1.91B +13.4%
Net Income	-27.20M
EPS	-0.15
Shares Out	185.25M
PE Ratio	n/a
Forward PE	9.84
Dividend	0.07 (7.36%)
Ex-Dividend Date	Mar 26, 2026

Volume	279,110
Average Volume	156,940
Open	0.9490
Previous Close	0.9510
Day's Range	0.9460 - 0.9650
52-Week Range	0.9410 - 1.2600
Beta	0.49
RSI	34.77
Earnings Date	Apr 29, 2026

About Oriola Oyj

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tenders, ...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1907
• Employees: 904
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: ORIOLA

Financial Performance

In 2025, Oriola Oyj's revenue was 1.91 billion, an increase of 13.40% compared to the previous year's 1.68 billion. Losses were -27.20 million, 35.3% more than in 2024.